TRDA - Entrada Therapeutics GAAP EPS of -$0.21 revenue of $25.26M May, 10 2023 01:51 PM Entrada Therapeutics Inc. 2023-05-10 13:51:57 ET Entrada Therapeutics press release ( NASDAQ: TRDA ): Q1 GAAP EPS of -$0.21. Revenue of $25.26M. For further details see: Entrada Therapeutics GAAP EPS of -$0.21, revenue of $25.26M